Connect to share and comment

U.S. Supreme Court tosses out Medtronic pacemaker patent loss

WASHINGTON (Reuters) - The U.S. Supreme Court on Wednesday ruled in favor of medical devices maker Medtronic Inc in its dispute with privately owned Mirowski Family Ventures LLC over whether the larger company infringed on Mirowski's patents in making certain pacemakers. The case stems from Medtronic's decision to ask a judge to rule that some of its pacemakers do not infringe on technology patented by Mirowski and licensed to Boston Scientific as well as Guidant Corp, part of Boston Scientific and Abbott Laboratories.

Ex-University of Michigan Alzheimer's expert says he lost job after passing secrets to trader

NEW YORK, N.Y. - A former top Alzheimer's researcher told a Manhattan jury Friday that he had to quit teaching at the University of Michigan, because he shared secrets about a drug trial with a hedge fund trader who won him over with some sandwiches and perceptive questions about science and medicine. Sidney Gilman, 81, of Ann Arbor, Mich., testified at the trial of former SAC Capital Advisors portfolio manager Mathew Martoma that some secrets about the clinical drug trial for a promising Alzheimer's drug "slipped" out during a meeting with Martoma in 2006 or 2007.

FDA approves 6 low-cost versions of blockbuster antidepressant pill Cymbalta

WASHINGTON - The Food and Drug Administration has approved the first generic versions of the blockbuster antidepressant Cymbalta, offering lower-cost access to one of the most widely prescribed treatments for depression, anxiety and other disorders. Cymbalta is Eli Lilly Besides depression, Cymbalta is also prescribed to treat generalized anxiety disorder, diabetic nerve pain, fibromyalgia and forms of chronic pain.

Lilly depression drug fails late-stage trials

By Ransdell Pierson (Reuters) - Eli Lilly and Co said on Thursday it would not seek approval for edivoxetine, its experimental drug to treat major depression, after it failed to meet its primary goal in three late-stage trials. Edivoxetine, a member of a family of medicines called norepinephrine reuptake inhibitors, was tested in combination with a member of a widely used class of depression treatments known as selective serotonin reuptake inhibitors (SSRIs) in each of the three trials.

Lloyds Banking Group names Norman Blackwell to succeed Winfried Bischoff as chairman

LONDON - Lloyds Banking Group PLC has named Norman Blackwell to the role of chairman, succeeding Winfried Bischoff when he retires next year. The bank said in a statement Monday that Blackwell, who has been a non-executive director, will succeed Bischoff as chairman beginning in April. He is currently chairman of Lloyd's Scottish Widows Group and has experience in insurance, banking and public policy. Blackwell was also partner in the management consultancy McKinsey

Lilly to pump in $700 million to boost insulin making capacity

(Reuters) - Eli Lilly and Co said it will invest more than $700 million to boost its insulin manufacturing capacity in Puerto Rico, France, China and the United States. The company's traditional stronghold has been its diabetes treatments, but the sales of its drugs have been suffering due to increasing competition from companies including Denmark's Novo Nordisk.

Butler 89, Lamar 58

Butler 89, Lamar 58: Khyle Marshall had 19 points and 13 rebounds as the host Bulldogs made a winner of Brandon Miller in his head coaching debut. Kellen Dunham struggled with his shooting early before finishing with 13 points for Butler. Kameron Woods added 11 points on 5-for-6 shooting and Erik Fromm finished with 10 points for the Bulldogs (1-0).

RugbyU: Doping ban for female NZealand sevens player

New Zealand women's sevens player Lavinia Gould has been banned for two years after testing positive for a banned stimulant, officials said Friday. The International Rugby Board imposed the ban after tests conducted at an international sevens tournament in Dubai found the stimulant methylhexaneamine in Gould's system. New Zealand Rugby Union chief executive Steve Tew said the substance was in a dietary supplement that Gould had taken, even though it had not been approved by medical staff. "We are very disappointed this has occurred," he said in a statement.

Insight: U.S. farm kids lavish shampoos and drugs on their prize cattle

By Lisa Baertlein and P.J. Huffstutter DALLAS (Reuters) - For more than a century, ranchers and their kids have paraded cattle around the dusty show ring at the State Fair of Texas in Dallas, in a rite of passage that is part farm economics, part rural theater.

Boston Scientific stents lag, CFO resigns, shares fall

By Ransdell Pierson (Reuters) - Boston Scientific Corp <BSX.N>, which is in the midst of an attempted turnaround, reported weak sales of its heart stents and provided a disappointing fourth-quarter company sales forecast, sending its shares almost 7 percent lower on Thursday. The medical device maker also caused market jitters by announcing that Jeffrey Capello, its chief financial officer since early 2010, would resign effective December 31. He will be replaced by Daniel Brennan, the company's corporate controller.
Syndicate content